Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (36)

2022

  1. Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification

    Scientific Reports, Vol. 12, Núm. 1

  2. [Translated article] Drug Resistant Tuberculosis: New WHO Definitions and Their Implication in the SEPAR Guideline

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. T87-T89

2021

  1. Diagnosis of tuberculous infection in immunosuppressed patients and/or candidates for biologics using a combination of 2 IGRA tests: T-SPOT.TB/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB/QuantiFERON TB Gold Plus

    Archivos de Bronconeumologia

  2. Drug Resistant Tuberculosis: New WHO Definitions and Their Implication in the SEPAR Guideline

    Archivos de Bronconeumologia

  3. New Research Strategies in Latent Tuberculosis Infection

    Archivos de Bronconeumologia

2020

  1. A strategy based on Amplified Fragment Length Polymorphism (AFLP) for routine genotyping of nontuberculous mycobacteria at the clinical laboratory

    Molecular Biology Reports, Vol. 47, Núm. 5, pp. 3397-3405

  2. Diagnosis of Tuberculous Infection in Immunosuppressed Patients and/or Candidates for Biologics Using a Combination of 2 IGRA Tests: T-SPOT.TB/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB/QuantiFERON TB Gold Plus

    Archivos de Bronconeumologia

  3. Ethambutol-resistant Mycobacterium kansasii cervical lymphadenitis in an immunocompetent adult patient: A case report and literature review

    Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol. 18

  4. Nuevas perspectivas en infección tuberculosa latente

    Archivos de bronconeumologia

  5. Update of SEPAR guideline «Diagnosis and Treatment of Drug-Resistant Tuberculosis»

    Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 514-521

2019

  1. Buruli ulcers in a Spanish aid worker after a stay in Peru

    International Journal of Infectious Diseases

  2. Desertomycin G, a new antibiotic with activity against mycobacterium tuberculosis and human breast tumor cell lines produced by streptomyces althioticus MSM3, isolated from the cantabrian sea intertidal macroalgae ulva sp.

    Marine Drugs, Vol. 17, Núm. 2

2018

  1. Comments on the SEPAR Guidelines for the Diagnosis and Treatment of Drug-Resistant Tuberculosis

    Archivos de Bronconeumologia

  2. High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?

    Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 3, pp. 538-546

  3. How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 24, Núm. 6, pp. 599-603

2017

  1. Branimycins B and C, Antibiotics Produced by the Abyssal Actinobacterium Pseudonocardia carboxydivorans M-227

    Journal of Natural Products, Vol. 80, Núm. 2, pp. 569-573

  2. Diagnosis and Treatment of Drug-Resistant Tuberculosis

    Archivos de Bronconeumologia, Vol. 53, Núm. 9, pp. 501-509

  3. Diagnostic accuracy of the Xpert® MTB/RIF cycle threshold level to predict smear positivity: A meta-analysis

    International Journal of Tuberculosis and Lung Disease, Vol. 21, Núm. 5, pp. 493-502

  4. Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos

    Archivos de Bronconeumologia, Vol. 53, Núm. 9, pp. 501-509

  5. Methods for determining the antimicrobial susceptibility of mycobacteria

    Enfermedades Infecciosas y Microbiologia Clinica